-
1
-
-
4544327596
-
Relation between renal dysfunction and cardiovascular outcomes after myocardial infarction
-
DOI 10.1056/NEJMoa041365
-
Anavekar, N.S., McMurray, J.J.V., Velazquez, E.J., Solomon, S.D., Kober, L., Rouleau, J.-L., et al.. (2004). Relation between renal dysfunction and cardiovascular outcomes after myocardial infarction. N Engl J Med 351, 1285-1295 (Pubitemid 39258422)
-
(2004)
New England Journal of Medicine
, vol.351
, Issue.13
, pp. 1285-1295
-
-
Anavekar, N.S.1
McMurray, J.J.V.2
Velazquez, E.J.3
Solomon, S.D.4
Kober, L.5
Rouleau, J.-L.6
White, H.D.7
Nordlander, R.8
Maggioni, A.9
Dickstein, K.10
Zelenkofske, S.11
Leimberger, J.D.12
Califf, R.M.13
Pfeffer, M.A.14
-
2
-
-
40749121688
-
The contribution of ApoB and ApoA1 measurements to cardiovascular risk assessment
-
DOI 10.1111/j.1463-1326.2007.00714.x
-
Andrikoula, M., and McDowell, I.F.W. (2008). The contribution of ApoB and ApoA1 measurements to cardiovascular risk assessment. Diabetes Obes Metab 10, 271-278 (Pubitemid 351386024)
-
(2008)
Diabetes, Obesity and Metabolism
, vol.10
, Issue.4
, pp. 271-278
-
-
Andrikoula, M.1
Mcdowell, I.F.W.2
-
3
-
-
0034069495
-
Gene ontology: Tool for the unification of biology
-
DOI 10.1038/75556
-
Ashburner, M., Ball, C.A., Blake, J.A., Botstein, D., Butler, H., Cherry, J.M., et al.. (2000). Gene ontology: tool for the unification of biology. The Gene Ontology Consortium. Nat Genet 25, 25-29 (Pubitemid 30257031)
-
(2000)
Nature Genetics
, vol.25
, Issue.1
, pp. 25-29
-
-
Ashburner, M.1
Ball, C.A.2
Blake, J.A.3
Botstein, D.4
Butler, H.5
Cherry, J.M.6
Davis, A.P.7
Dolinski, K.8
Dwight, S.S.9
Eppig, J.T.10
Harris, M.A.11
Hill, D.P.12
Issel-Tarver, L.13
Kasarskis, A.14
Lewis, S.15
Matese, J.C.16
Richardson, J.E.17
Ringwald, M.18
Rubin, G.M.19
Sherlock, G.20
more..
-
4
-
-
0031783758
-
The compositional abnormalities of lipoproteins in diabetic renal failure
-
DOI 10.1093/ndt/13.11.2833
-
Attman, P.O., Knight-Gibson, C., Tavella, M., Samuelsson, O., and Alaupovic, P. (1998). The compositional abnormalities of lipoproteins in diabetic renal failure. Nephrol Dial Transplant 13, 2833-2841 (Pubitemid 28479531)
-
(1998)
Nephrology Dialysis Transplantation
, vol.13
, Issue.11
, pp. 2833-2841
-
-
Attman, P.-O.1
Knight-Gibson, C.2
Tavella, M.3
Samuelsson, O.4
Alaupovic, P.5
-
5
-
-
33846031473
-
Kidney-heart interactions: Epidemiology, pathogenesis, and treatment
-
Berl, T., and Henrich, W. (2006). Kidney-heart interactions: epidemiology, pathogenesis, and treatment. Clin J Am Soc Nephrol 1, 8-18
-
(2006)
Clin. J. Am. Soc. Nephrol.
, vol.1
, pp. 8-18
-
-
Berl, T.1
Henrich, W.2
-
6
-
-
13544261698
-
The severe cardiorenal syndrome: 'Guyton revisited'
-
DOI 10.1093/eurheartj/ehi020
-
Bongartz, L.G., Cramer, M.J., Doevendans, P.A., Joles, J.A., and Braam, B. (2005). The severe cardiorenal syndrome: "Guyton revisited." Eur Heart J 26, 11-17 (Pubitemid 40221118)
-
(2005)
European Heart Journal
, vol.26
, Issue.1
, pp. 11-17
-
-
Bongartz, L.G.1
Cramer, M.J.2
Doevendans, P.A.3
Joles, J.A.4
Braam, B.5
-
7
-
-
0030512150
-
Transforming growth factor β in diabetic nephropathy
-
DOI 10.1002/(SICI)1099-0895(199612)12:4<309::AID-DMR171>3.0.CO;2-A
-
Border, W.A., Yamamoto, T., and Noble, N.A. (1996). Transforming growth factor beta in diabetic nephropathy. Diabetes Metab Rev 12, 309-339 (Pubitemid 27062225)
-
(1996)
Diabetes/Metabolism Reviews
, vol.12
, Issue.4
, pp. 309-339
-
-
Border, W.A.1
Yamamoto, T.2
Noble, N.A.3
-
8
-
-
41449096186
-
Increased expression of light/ tnfsf14 and its receptors in experimental and clinical heart failure
-
Dahl, C.P., Gullestad, L., Fevang, B., Holm, A.M., Landrø, L., Vinge, L.E., et al.. (2008). Increased expression of LIGHT/ TNFSF14 and its receptors in experimental and clinical heart failure. Eur J Heart Failure 10, 352-359
-
(2008)
Eur. J. Heart Failure.
, vol.10
, pp. 352-359
-
-
Dahl, C.P.1
Gullestad, L.2
Fevang, B.3
Holm, A.M.4
Landrø, L.5
Vinge, L.E.6
-
9
-
-
40449111684
-
Accelerated arterial stiffening and gene expression profile of the aorta in patients with coronary artery disease
-
DOI 10.1097/HJH.0b013e3282f4b3d0, PII 0000487220080400000021
-
Fassot, C., Briet, M., Rostagno, P., Barbry, P., Perret, C., Laude, D., et al.. (2008). Accelerated arterial stiffening and gene expression profile of the aorta in patients with coronary artery disease. J Hypertens 26, 747-757 (Pubitemid 351354923)
-
(2008)
Journal of Hypertension
, vol.26
, Issue.4
, pp. 747-757
-
-
Fassot, C.1
Briet, M.2
Rostagno, P.3
Barbry, P.4
Perret, C.5
Laude, D.6
Boutouyrie, P.7
Bozec, E.8
Bruneval, P.9
Latremouille, C.10
Laurent, S.11
-
10
-
-
79957614666
-
Mapping of molecular pathways, biomarkers and drug targets for diabeticnephropathy
-
Fechete, R., Heinzel, A., Perco, P., Mönks, K., Söllner, J., Stelzer, G., et al.. (2011). Mapping of molecular pathways, biomarkers and drug targets for diabeticnephropathy. Proteomics Clin Appl 5, 354-366
-
(2011)
Proteomics Clin. Appl.
, vol.5
, pp. 354-366
-
-
Fechete, R.1
Heinzel, A.2
Perco, P.3
Mönks, K.4
Söllner, J.5
Stelzer, G.6
-
11
-
-
0032731318
-
The tubulointerstitium in progressive diabetic kidney disease: More than an aftermath of glomerular injury?
-
DOI 10.1046/j.1523-1755.1999.00721.x
-
Gilbert, R.E., and Cooper, M.E. (1999). The tubulointerstitium in progressive diabetic kidney disease: more than an aftermath of glomerular injury? Kidney Int 56, 1627-1637 (Pubitemid 29518163)
-
(1999)
Kidney International
, vol.56
, Issue.5
, pp. 1627-1637
-
-
Gilbert, R.E.1
Cooper, M.E.2
-
12
-
-
0015110675
-
Relationship of cardiorenal function to renin-aldosterone system in patients with valvular heart disease
-
Judson, W.E., and Helmer, O.M. (1971). Relationship of cardiorenal function to renin-aldosterone system in patients with valvular heart disease. Circulation 44, 245-253
-
(1971)
Circulation
, vol.44
, pp. 245-253
-
-
Judson, W.E.1
Helmer, O.M.2
-
13
-
-
0033982936
-
KEGG: Kyoto encyclopedia of genes and genomes
-
Kanehisa, M., and Goto, S. (2000). KEGG: kyoto encyclopedia of genes and genomes. Nucleic Acids Res 28, 27-30 (Pubitemid 30047706)
-
(2000)
Nucleic Acids Research
, vol.28
, Issue.1
, pp. 27-30
-
-
Kanehisa, M.1
Goto, S.2
-
14
-
-
30944466704
-
Overview of hemostatic factors involved in atherosclerotic cardiovascular disease
-
DOI 10.1007/s11745-005-1488-8, L9745
-
Kannel, W.B. (2005). Overview of hemostatic factors involved in atherosclerotic cardiovascular disease. Lipids 40, 1215-1220 (Pubitemid 43117845)
-
(2005)
Lipids
, vol.40
, Issue.12
, pp. 1215-1220
-
-
Kannel, W.B.1
-
15
-
-
33846047770
-
IntAct - Open source resource for molecular interaction data
-
DOI 10.1093/nar/gkl958
-
Kerrien, S., Alam-Faruque, Y., Aranda, B., Bancarz, I., Bridge, A., Derow, C., et al.. (2007). IntAct-open source resource for molecular interaction data. Nucleic Acids Res 35, D561-D565 (Pubitemid 46056270)
-
(2007)
Nucleic Acids Research
, vol.35
, Issue.SUPPL. 1
-
-
Kerrien, S.1
Alam-Faruque, Y.2
Aranda, B.3
Bancarz, I.4
Bridge, A.5
Derow, C.6
Dimmer, E.7
Feuermann, M.8
Friedrichsen, A.9
Huntley, R.10
Kohler, C.11
Khadake, J.12
Leroy, C.13
Liban, A.14
Lieftink, C.15
Montecchi-Palazzi, L.16
Orchard, S.17
Risse, J.18
Robbe, K.19
Roechert, B.20
Thorneycroft, D.21
Zhang, Y.22
Apweiler, R.23
Hermjakob, H.24
more..
-
16
-
-
0030721722
-
Fibrinogen and fibrinolytic activity in CAPD patients with atherosclerosis and its correlation with serum albumin
-
Kim, K.J., Yang, W.S., Kim, S.B., Lee, S.K., and Park, J.S. (1997). Fibrinogen and fibrinolytic activity in CAPD patients with atherosclerosis and its correlation with serum albumin. Peritoneal Dial Int 17, 157-161 (Pubitemid 27474772)
-
(1997)
Peritoneal Dialysis International
, vol.17
, Issue.2
, pp. 157-161
-
-
Kim, K.J.1
Yang, W.S.2
Kim, S.B.3
Lee, S.K.4
Park, J.S.5
-
17
-
-
32044449192
-
Validity of plasma fibrinogen, D-dimer, and the von Willebrand factor as markers of cardiovascular morbidity in patients on chronic hemodialysis
-
Kirmizis, D., Tsiandoulas, A., Pangalou, M., Koutoupa, E., Rozi, P., Protopappa, M., et al.. (2006). Validity of plasma fibrinogen, D-dimer, and the von Willebrand factor as markers of cardiovascular morbidity in patients on chronic hemodialysis. Med Sci Monitor 12, CR55-CR62 (Pubitemid 43200944)
-
(2006)
Medical Science Monitor
, vol.12
, Issue.2
-
-
Kirmizis, D.1
Tsiandoulas, A.2
Pangalou, M.3
Koutoupa, E.4
Rozi, P.5
Protopappa, M.6
Barboutis, K.7
-
18
-
-
84856617910
-
Therapeutic options for the management of the cardiorenal syndrome
-
Koniari, K., Nikolaou, M., Paraskevaidis, I., and Parissis, J. (2010). Therapeutic options for the management of the cardiorenal syndrome. Int J Nephrol 2011, 194910
-
(2010)
Int. J. Nephrol 2011
, pp. 194910
-
-
Koniari, K.1
Nikolaou, M.2
Paraskevaidis, I.3
Parissis, J.4
-
19
-
-
33750604403
-
Blockade of angiotensin II type-1 receptor reduces oxidative stress in adipose tissue and ameliorates adipocytokine dysregulation
-
DOI 10.1038/sj.ki.5001810, PII 5001810
-
Kurata, A., Nishizawa, H., Kihara, S., Maeda, N., Sonoda, M., Okada, T., et al.. (2006). Blockade of angiotensin II type-1 receptor reduces oxidative stress in adipose tissue and ameliorates adipocytokine dysregulation. Kidney Int 70, 1717-1724 (Pubitemid 44684802)
-
(2006)
Kidney International
, vol.70
, Issue.10
, pp. 1717-1724
-
-
Kurata, A.1
Nishizawa, H.2
Kihara, S.3
Maeda, N.4
Sonoda, M.5
Okada, T.6
Ohashi, K.7
Hibuse, T.8
Fujita, K.9
Yasui, A.10
Hiuge, A.11
Kumada, M.12
Kuriyama, H.13
Shimomura, I.14
Funahashi, T.15
-
20
-
-
0037823130
-
Vasopressin: A new target for the treatment of heart failure
-
DOI 10.1016/S0002-8703(02)94708-3
-
Lee, C.R., Watkins, M.L., Patterson, J.H., Gattis, W., O'Connor, C.M., Gheorghiade, M., et al.. (2003). Vasopressin: a new target for the treatment of heart failure. Am Heart J 146, 9-18 (Pubitemid 36851295)
-
(2003)
American Heart Journal
, vol.146
, Issue.1
, pp. 9-18
-
-
Lee, C.R.1
Watkins, M.L.2
Patterson, J.H.3
Gattis, W.4
O'Connor, C.M.5
Gheorghiade, M.6
Adams Jr., K.F.7
-
21
-
-
27944442216
-
Peroxisome proliferator-activated receptor β/δ exerts a strong protection from ischemic acute renal failure
-
DOI 10.1681/ASN.2004090802
-
Letavernier, E., Perez, J., Joye, E., Bellocq, A., Fouqueray, B., Haymann, J.-P., et al.. (2005). Peroxisome proliferator-activated receptor beta/delta exerts a strong protection from ischemic acute renal failure. J Am Soc Nephrol 16, 2395-2402 (Pubitemid 41725057)
-
(2005)
Journal of the American Society of Nephrology
, vol.16
, Issue.8
, pp. 2395-2402
-
-
Letavernier, E.1
Perez, J.2
Joye, E.3
Bellocq, A.4
Fouqueray, B.5
Haymann, J.-P.6
Heudes, D.7
Wahli, W.8
Desvergne, B.9
Baud, L.10
-
22
-
-
0016403709
-
Accelerated atherosclerosis in prolonged maintenance hemodialysis
-
Lindner, A., Charra, B., Sherrard, D.J., and Scribner, B.H. (1974). Accelerated atherosclerosis in prolonged maintenance hemodialysis. N Engl J Med 290, 697-701
-
(1974)
N. Engl. J. Med.
, vol.290
, pp. 697-701
-
-
Lindner, A.1
Charra, B.2
Sherrard, D.J.3
Scribner, B.H.4
-
23
-
-
70149118042
-
Antihypertensive pharmacogenetic effect of fibrinogen-beta variant - 455G >A on cardiovascular disease, end-stage renal disease, and mortality: The genhat study
-
Lynch, A.I., Boerwinkle, E., Davis, B.R., Ford, C.E., Eckfeldt, J.H., Leiendecker-Foster, C., et al.. (2009). Antihypertensive pharmacogenetic effect of fibrinogen-beta variant - 455G >A on cardiovascular disease, end-stage renal disease, and mortality: the GenHAT study. Pharmacogenet Genomics 19, 415-421
-
(2009)
Pharmacogenet Genomics
, vol.19
, pp. 415-421
-
-
Lynch, A.I.1
Boerwinkle, E.2
Davis, B.R.3
Ford, C.E.4
Eckfeldt, J.H.5
Leiendecker-Foster, C.6
-
24
-
-
77950342584
-
Cardiorenal interaction: Appropriate treatment of cardiovascular risk factors to improve outcomes in chronic kidney disease
-
McCullough, P.A., and Verrill, T.A. (2010). Cardiorenal interaction: appropriate treatment of cardiovascular risk factors to improve outcomes in chronic kidney disease. Postgrad Med 122, 25-34
-
(2010)
Postgrad. Med.
, vol.122
, pp. 25-34
-
-
Mc Cullough, P.A.1
Verrill, T.A.2
-
25
-
-
0033563007
-
Cutting edge: C1q protects against the development of glomerulonephritis independently of C3 activation
-
Mitchell, D.A., Taylor, P.R., Cook, H.T., Moss, J., Bygrave, A.E., Walport, M.J., et al.. (1999). Cutting edge: C1q protects against the development of glomerulonephritis independently of C3 activation. J Immunol 162, 5676-5679 (Pubitemid 29314916)
-
(1999)
Journal of Immunology
, vol.162
, Issue.10
, pp. 5676-5679
-
-
Mitchell, D.A.1
Taylor, P.R.2
Cook, H.T.3
Moss, J.4
Bygrave, A.E.5
Walport, M.J.6
Botto, M.7
-
26
-
-
33751192457
-
Haemostatic factors and the risk of cardiovascular death in patients with coronary artery disease: The AtheroGene study
-
Morange, P.E., Bickel, C., Nicaud, V., Schnabel, R., Rupprecht, H.J., Peetz, D., et al.. (2006). Haemostatic factors and the risk of cardiovascular death in patients with coronary artery disease: the AtheroGene study. Arterioscler Thromb Vasc Biol 26, 2793-2799
-
(2006)
Arterioscler Thromb. Vasc. Biol.
, vol.26
, pp. 2793-2799
-
-
Morange, P.E.1
Bickel, C.2
Nicaud, V.3
Schnabel, R.4
Rupprecht, H.J.5
Peetz, D.6
-
27
-
-
84859788820
-
Integrative bioinformatics analysis of proteins associated with the cardiorenal syndrome
-
Mühlberger, I., Moenks, K., Bernthaler, A., Jandrasits, C., Mayer, B., Mayer, G., et al.. (2010). Integrative bioinformatics analysis of proteins associated with the cardiorenal syndrome. Int J Nephrol 2011, 809378
-
(2010)
Int. J. Nephrol
, pp. 809378
-
-
MüHlberger, I.1
Moenks, K.2
Bernthaler, A.3
Jandrasits, C.4
Mayer, B.5
Mayer, G.6
-
28
-
-
0031706340
-
The tubulointerstitium in progressive renal disease
-
DOI 10.1046/j.1523-1755.1998.00079.x
-
Nath, K.A. (1998). The tubulointerstitium in progressive renal disease. Kidney Int 54, 992-994 (Pubitemid 28397421)
-
(1998)
Kidney International
, vol.54
, Issue.3
, pp. 992-994
-
-
Nath, K.A.1
-
29
-
-
77952834144
-
Linking transcriptomic and proteomic data on the level of protein interaction networks
-
Perco, P., Mühlberger, I., Mayer, G., Oberbauer, R., Lukas, A., and Mayer, B. (2010). Linking transcriptomic and proteomic data on the level of protein interaction networks. Electrophoresis 31, 1780-1789
-
(2010)
Electrophoresis
, vol.31
, pp. 1780-1789
-
-
Perco, P.1
Mühlberger, I.2
Mayer, G.3
Oberbauer, R.4
Lukas, A.5
Mayer, B.6
-
30
-
-
54449098488
-
Cardiorenal syndrome
-
Ronco, C., Haapio, M., House, A.A., Anavekar, N., and Bellomo, R. (2008). Cardiorenal syndrome. J Am College Cardiol 52, 1527-1539
-
(2008)
J. Am. College. Cardiol.
, vol.52
, pp. 1527-1539
-
-
Ronco, C.1
Haapio, M.2
House, A.A.3
Anavekar, N.4
Bellomo, R.5
-
31
-
-
77954601208
-
Cardiorenal syndromes: An executive summary from the consensus conference of the acute dialysis quality initiative (adqi
-
Ronco, C., McCullough, P.A., Anker, S.D., Anand, I., Aspromonte, N., Bagshaw, S.M., et al.. (2010). Cardiorenal syndromes: an executive summary from the consensus conference of the Acute Dialysis Quality Initiative (ADQI). Contrib Nephrol 165, 54-67
-
(2010)
Contrib Nephrol
, vol.165
, pp. 54-67
-
-
Ronco, C.1
Mc Cullough, P.A.2
Anker, S.D.3
Anand, I.4
Aspromonte, N.5
Bagshaw, S.M.6
-
32
-
-
0022825988
-
The epidemiology of coronary artery disease in patients on maintenance hemodialysis: Implications for management
-
Rostand, S.G., Kirk, K.A., and Rutsky, E.A. (1986). The epidemiology of coronary artery disease in patients on maintenance hemodialysis: implications for management. Contrib Nephrol 52, 34-41
-
(1986)
Contrib Nephrol
, vol.52
, pp. 34-41
-
-
Rostand, S.G.1
Kirk, K.A.2
Rutsky, E.A.3
-
33
-
-
34548624338
-
Fenofibrate and pioglitazone improve endothelial function and reduce arterial stiffness in obese glucose tolerant men
-
DOI 10.1016/j.atherosclerosis.2006.11.007, PII S0021915006006812
-
Ryan, K.E., McCance, D.R., Powell, L., McMahon, R., and Trimble, E.R. (2007). Fenofibrate and pioglitazone improve endothelial function and reduce arterial stiffness in obese glucose tolerant men. Atherosclerosis 194, e123-e130 (Pubitemid 47513101)
-
(2007)
Atherosclerosis
, vol.194
, Issue.2
-
-
Ryan, K.E.1
McCance, D.R.2
Powell, L.3
McMahon, R.4
Trimble, E.R.5
-
34
-
-
0242441465
-
Kidney Disease as a Risk Factor for Development of Cardiovascular Disease: A Statement from the American Heart Association Councils on Kidney in Cardiovascular Disease, High Blood Pressure Research, Clinical Cardiology, and Epidemiology and Prevention
-
DOI 10.1161/01.HYP.0000102971.85504.7c
-
Sarnak, M.J., Levey, A.S., Schoolwerth, A.C., Coresh, J., Culleton, B., Hamm, L.L., et al.. (2003). Kidney disease as a risk factor for development of cardiovascular disease: a statement from the American Heart Association Councils on Kidney in Cardiovascular Disease, High Blood Pressure Research, Clinical Cardiology, and Epidemiology and Prevention. Hypertension 42, 1050-1065 (Pubitemid 37413751)
-
(2003)
Hypertension
, vol.42
, Issue.5
, pp. 1050-1065
-
-
Sarnak, M.J.1
Levey, A.S.2
Schoolwerth, A.C.3
Coresh, J.4
Culleton, B.5
Hamm, L.L.6
McCullough, P.A.7
Kasiske, B.L.8
Kelepouris, E.9
Klag, M.J.10
Parfrey, P.11
Pfeffer, M.12
Raij, L.13
Spinosa, D.J.14
Wilson, P.W.15
-
35
-
-
23244468300
-
More evidence of cardiorenal protective effects of peroxisome proliferator-activated receptor activation
-
DOI 10.1161/01.HYP.0000172756.41375.e4
-
Schiffrin, E.L. (2005). More evidence of cardiorenal protective effects of peroxisome proliferator-activated receptor activation. Hypertension 46, 267-268 (Pubitemid 41099154)
-
(2005)
Hypertension
, vol.46
, Issue.2
, pp. 267-268
-
-
Schiffrin, E.L.1
-
36
-
-
34347350171
-
Chronic kidney disease: Effects on the cardiovascular system
-
DOI 10.1161/CIRCULATIONAHA.106.678342, PII 0000301720070703000015
-
Schiffrin, E.L., Lipman, M.L., and Mann, J.F.E. (2007). Chronic kidney disease: effects on the cardiovascular system. Circulation 116, 85-97 (Pubitemid 47016250)
-
(2007)
Circulation
, vol.116
, Issue.1
, pp. 85-97
-
-
Schiffrin, E.L.1
Lipman, M.L.2
Mann, J.F.E.3
-
37
-
-
33845526226
-
Modular activation of nuclear factor-κB transcriptional programs in human diabetic nephropathy
-
DOI 10.2337/db06-0477
-
Schmid, H., Boucherot, A., Yasuda, Y., Henger, A., Brunner, B., Eichinger, F., et al.. (2006). Modular activation of nuclear factor- kappaB transcriptional programs in human diabetic nephropathy. Diabetes 55, 2993-3003 (Pubitemid 44923635)
-
(2006)
Diabetes
, vol.55
, Issue.11
, pp. 2993-3003
-
-
Schmid, H.1
Boucherot, A.2
Yasuda, Y.3
Henger, A.4
Brunner, B.5
Eichinger, F.6
Nitsche, A.7
Kiss, E.8
Bleich, M.9
Grone, H.-J.10
Nelson, P.J.11
Schlondorff, D.12
Cohen, C.D.13
Kretzler, M.14
-
38
-
-
67649397446
-
Inflammation in chronic kidney disease: Role in the progression of renal and cardiovascular disease
-
Silverstein, D.M. (2009). Inflammation in chronic kidney disease: role in the progression of renal and cardiovascular disease. Pediatr Nephrol 24, 1445-1452
-
(2009)
Pediatr. Nephrol.
, vol.24
, pp. 1445-1452
-
-
Silverstein, D.M.1
-
39
-
-
34547907069
-
Fibrin clot structure in patients with end-stage renal disease
-
DOI 10.1160/TH06-12-0715
-
Sjøland, J.A., Sidelmann, J.J.,Brabrand,M.,Pedersen, R.S.,Pedersen, J.H., Esbensen, K., et al.. (2007). Fibrin clot structure in patients with end-stage renal disease. Thromb Haemostasis 98, 339-345 (Pubitemid 47250237)
-
(2007)
Thrombosis and Haemostasis
, vol.98
, Issue.2
, pp. 339-345
-
-
Sjoland, J.A.1
Sidelmann, J.J.2
Brabrand, M.3
Pedersen, R.S.4
Pedersen, J.H.5
Esbensen, K.6
Standeven, K.F.7
Ariens, R.A.S.8
Gram, J.9
-
40
-
-
44649141518
-
Effect of peroxisome proliferator-activated receptor-α ligands in the interaction between adipocytes and macrophages in obese adipose tissue
-
DOI 10.1038/oby.2008.62, PII OBY200862
-
Toyoda, T., Kamei, Y., Kato, H., Sugita, S., Takeya, M., Suganami, T., et al.. (2008). Effect of peroxisome proliferatoractivated receptor-alpha ligands in the interaction between adipocytes and macrophages in obese adipose tissue. Obesity 16, 1199-1207 (Pubitemid 351771340)
-
(2008)
Obesity
, vol.16
, Issue.6
, pp. 1199-1207
-
-
Toyoda, T.1
Kamei, Y.2
Kato, H.3
Sugita, S.4
Takeya, M.5
Suganami, T.6
Ogawa, Y.7
-
41
-
-
34547684022
-
Distinctive expression of chemokines and transforming growth factor-β signaling in human arterial endothelium during atherosclerosis
-
DOI 10.2353/ajpath.2007.061196
-
Volger, O.L., Fledderus, J.O., Kisters, N., Fontijn, R.D., Moerland, P.D., Kuiper, J., et al.. (2007). Distinctive expression of chemokines and transforming growth factor-beta signaling in human arterial endothelium during atherosclerosis. Am J Pathol 171, 326-337 (Pubitemid 47339249)
-
(2007)
American Journal of Pathology
, vol.171
, Issue.1
, pp. 326-337
-
-
Volger, O.L.1
Fledderus, J.O.2
Kisters, N.3
Fontijn, R.D.4
Moerland, P.D.5
Kuiper, J.6
Van Berkel, T.J.7
Bijnens, A.-P.J.J.8
Daemen, M.J.A.P.9
Pannekoek, H.10
Horrevoets, A.J.G.11
-
42
-
-
34948859481
-
The peroxisome proliferator-activated receptor-γ agonist pioglitazone increases number and function of endothelial progenitor cells in patients with coronary artery disease and normal glucose tolerance
-
DOI 10.2337/db07-0069
-
Werner, C., Kamani, C.H., Gensch, C., Bohm, M. and Laufs, U. (2007). The peroxisome proliferator-activated receptor-gamma agonist pioglitazone increases number and function of endothelial progenitor cells in patients with coronary artery disease and normal glucose tolerance. Diabetes 56, 2609-2615 (Pubitemid 47523269)
-
(2007)
Diabetes
, vol.56
, Issue.10
, pp. 2609-2615
-
-
Werner, C.1
Kamani, C.H.2
Gensch, C.3
Bohm, M.4
Laufs, U.5
-
43
-
-
23244463712
-
Peroxisome proliferator-activated receptor-α activation reduces salt-dependent hypertension during chronic endothelin B receptor blockade
-
DOI 10.1161/01.HYP.0000172755.25382.fc
-
Williams, J.M., Zhao, X., Wang, M.H., Imig, J.D. and Pollock, D.M. (2005). Peroxisome proliferator-activated receptor-alpha activation reduces salt-dependent hypertension during chronic endothelin B receptor blockade. Hypertension 46, 366-371 (Pubitemid 41099171)
-
(2005)
Hypertension
, vol.46
, Issue.2
, pp. 366-371
-
-
Williams, J.M.1
Zhao, X.2
Wang, M.H.3
Imig, J.D.4
Pollock, D.M.5
|